China Medical System Holdings's revenue for the
six
months ended in Jun. 2024 was HK$3,887 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$7,610 Mil.
China Medical System Holdings's Revenue per Share for the
six
months ended in Jun. 2024 was HK$1.59.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$3.11.
Warning Sign:
China Medical System Holdings Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of China Medical System Holdings was -25.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, China Medical System Holdings's highest 3-Year average Revenue per Share Growth Rate was 32.40% per year. The lowest was -52.80% per year. And the median was 15.20% per year.
China Medical System Holdings Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Medical System Holdings's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Revenue distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's Revenue falls into.
China Medical System Holdings Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$7,610 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings (HKSE:00867) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
China Medical System Holdings Revenue Related Terms
Thank you for viewing the detailed overview of China Medical System Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
China Medical System Holdings Business Description
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00867 has been successfully added to your 